{"name":"EUROSPK Study Group","slug":"eurospk-study-group","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"sirolimus versus mycophenolate mofetil","genericName":"sirolimus versus mycophenolate mofetil","slug":"sirolimus-versus-mycophenolate-mofetil","indication":"Prevention of organ rejection in transplant recipients","status":"phase_3"}]}],"pipeline":[{"name":"sirolimus versus mycophenolate mofetil","genericName":"sirolimus versus mycophenolate mofetil","slug":"sirolimus-versus-mycophenolate-mofetil","phase":"phase_3","mechanism":"This is a comparative study of two immunosuppressive agents: sirolimus (mTOR inhibitor) and mycophenolate mofetil (IMPDH inhibitor), used to prevent organ rejection.","indications":["Prevention of organ rejection in transplant recipients","Renal transplantation"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOS01vUDVZczM2Q21vUHFqZHF6WVJMNmRPTTA0cTJWQTlabXpkX085TDBRZ2dHTDVBUm5QeWlMNUd0c0tKeHNRelVCTVl3czZtQlJyQkU4bVk3Z0Y5elNqOHlON0JaMU5FeExncy1Cc2thQUFyeVltc3dtQ19kSkJ6MURIUS1qcnhNaGJsUFhVa2hvQQ?oc=5","date":"2006-05-01","type":"pipeline","source":"Hospital Pharmacy Europe","summary":"Immunosuppression in kidney/pancreas transplant - Hospital Pharmacy Europe","headline":"Immunosuppression in kidney/pancreas transplant","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}